8-Cyclohexyl-1-thia-4,8-diazaspiro[4.5]decanehydrochloride
95%
- Product Code: 75762
CAS:
1221791-74-7
| Molecular Weight: | 276.87 g./mol | Molecular Formula: | C₁₃H₂₅ClN₂S |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD16140344 | |
| Melting Point: | 171-172℃ | Boiling Point: | |
| Density: | Storage Condition: | Room temperature, sealed, dry |
Product Description:
This compound is primarily utilized in the field of medicinal chemistry, particularly in the development of pharmaceutical agents. It serves as a key intermediate or building block in the synthesis of various biologically active molecules. Its structural features make it valuable for creating compounds with potential therapeutic effects, especially in targeting neurological disorders or as part of drug discovery programs. Researchers often explore its derivatives for their pharmacological properties, such as receptor binding or enzyme inhibition, to develop new treatments for diseases. Additionally, its spirocyclic structure contributes to its stability and bioavailability, making it a promising candidate for further optimization in drug design.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.500 | 10-20 days | $1,327.72 |
+
-
|
8-Cyclohexyl-1-thia-4,8-diazaspiro[4.5]decanehydrochloride
This compound is primarily utilized in the field of medicinal chemistry, particularly in the development of pharmaceutical agents. It serves as a key intermediate or building block in the synthesis of various biologically active molecules. Its structural features make it valuable for creating compounds with potential therapeutic effects, especially in targeting neurological disorders or as part of drug discovery programs. Researchers often explore its derivatives for their pharmacological properties, such as receptor binding or enzyme inhibition, to develop new treatments for diseases. Additionally, its spirocyclic structure contributes to its stability and bioavailability, making it a promising candidate for further optimization in drug design.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :